SPP1 and neoplasm: Given the efficacy of the anti-OPN Ab for inhibiting debris-stimulated tumor growth, we next systemically administered anti-OPN Ab as adjuvant therapy to 5-FU once CT26 tumors were established (100–200 mm3).